Alan Herbert, InsideOutBio, discusses the significant advancements in RNA therapeutics, highlighting their role in supporting ...

Oversubscribed Financing led by Coastlands Capital with participation from new and existing investors Financing to provide $50 million in upfront proceeds with the potential for up to an additional ...

Get the latest on Avidity Biosciences' late-stage RNA drug pipeline, upcoming FDA filings, and market opportunities for rare muscle diseases.

Avidity Biosciences, Inc. ( NASDAQ: RNA) Discusses on Redefining the Treatment of Duchenne Muscular Dystrophy Conference Call September 10, 2025 8:00 AM EDT ...

Detailed price information for Arrowhead Pharma (ARWR-Q) from The Globe and Mail including charting and trades.

About RestorAATion-2 RestorAATion-2 (NCT06405633) is an ongoing Phase 1b/2a open label study designed to evaluate the safety, tolerability, pharmacodynamics, and pharmacokinetics of WVE-006 in ...

Drs. Amy Proal and David Putrino will present the proposed study design for the consideration of RECOVER-TLC at the Second Annual RECOVER-TLC Workshop being held September 9-10, 2025 in Bethesda, ...

Summary: A new study suggests that autism may be linked to the rapid evolution of brain cell types unique to humans.

A record 48 horses have changed hands for seven figures through the first three days of the Keeneland September sale ...

CBSE Board exam for class 12 Chemistry will have different types of questions, like MCQs, assertion-based questions, ...